... disease, nerve damage, weak bones, fluid buildup, and hypertension 10% of Americans are affected by CKD ...
... would both decrease systolic blood pressure and albuminuria over 12 weeks Eligible patients: stage 4 ...
... SBP from baseline to 12 weeks was -11.0 mmHg in the chlorthalidone group and -0.5 mmHg in the placebo ...
... group The percent change in urinary albumin-tocreatinine ratio from baseline to 12 weeks was lower in ...
... controlled hypertension, chlorthalidone therapy improved blood pressure at 12 weeks as compared with placebo ...